2,3-Butanedione monoxime suppresses primarily total calcium handling in canine heart

Jpn J Physiol. 2000 Oct;50(5):543-51. doi: 10.2170/jjphysiol.50.543.

Abstract

Whether 2,3-butanedione monoxime (BDM, < or = 5mmol/l) suppresses primarily crossbridge cycling or total Ca(2+) handling in the blood-perfused whole heart remains controversial. Although BDM seems to suppress primarily total Ca(2+) handling in canine hearts, more evidence is lacking. We therefore analyzed the cardiac mechanoenergetics, namely, E(max) (contractility), PVA (total mechanical energy), and O(2) consumption of canine BDM-treated hearts by our recently developed integrative method to assess myocardial total Ca(2+) handling. This method additionally required the internal Ca(2+) recirculation fraction. We obtained this from the beat constant of the exponential decay component of the postextrasystolic potentiation. Our analysis indicated significant decreases in both internal Ca(2+) recirculation fraction and total Ca(2+) handling in the BDM-treated heart, but virtually no change in the reactivity of E(max) to total Ca(2+) handling. This result corroborates the view that BDM suppresses primarily total Ca(2+) handling rather than crossbridge cycling in the canine blood-perfused heart.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Arrhythmias, Cardiac / metabolism
  • Calcium / metabolism*
  • Diacetyl / analogs & derivatives*
  • Diacetyl / pharmacology*
  • Dogs
  • Enzyme Inhibitors / pharmacology*
  • In Vitro Techniques
  • Myocardial Contraction / drug effects*
  • Myocardial Contraction / physiology
  • Myocardium / metabolism*
  • Oxygen Consumption / drug effects
  • Oxygen Consumption / physiology
  • Sarcoplasmic Reticulum / drug effects
  • Sarcoplasmic Reticulum / metabolism
  • Ventricular Function, Left

Substances

  • Enzyme Inhibitors
  • diacetylmonoxime
  • Diacetyl
  • Calcium